Help us improve this page by adding information.
Visit our Writing Guide or this topic page for additional help.
Visit our Writing Guide or this topic page for additional help.
Timeline
Funding Rounds
Patents
Further Resources
Title
Author
Link
Type
Date
News
Title
Author
Date
Publisher
Description
BioSpace
April 14, 2021
BioSpace
aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways, and Lonza today announced that the companies have entered into an agreement for the manufacture of ATYR2810, aTyr's monoclonal antibody targeting Neuropilin-2 (NRP2) that is currently in preclinical development for cancer.
Reuters Editorial
June 5, 2020
IN
Swiss contract drug manufacturer Lonza Group on Friday named Roche manager Pierre-Alain Ruffieux as its new chief executive, effective Nov. 1, underscoring its focus on its fast-growing pharmaceuticals business.